Dr. IBRAHIM YILDIZ
Snapshot Highlights
- Expert in Medical Oncology with extensive experience.
- Published author with multiple contributions to leading medical journals.
- Board Member of the Lung Cancer Association.
- Affiliated with prestigious professional organizations including ESMO and ASCO.
Professional Experience
Dr. Ibrahim Yildiz is a distinguished Medical Oncologist with a career dedicated to advancing cancer care. His professional journey includes significant tenures at leading healthcare institutions. From 2015 onwards, he has been an integral part of the Acıbadem Health Group, contributing his expertise to patient treatment and research. Prior to this, he served at the Izmir Katip Celebi University Ataturk Training and Research Hospital in the Medical Oncology Clinic from 2013 to 2015, further solidifying his clinical acumen. His earlier career involved essential compulsory service at Kağıthane State Hospital from 2007 to 2009, and military service at the War Academies Command from 2009 to 2010, demonstrating a comprehensive background in healthcare service.
Education
Dr. Yildiz pursued his medical education with a strong academic foundation. He completed his specialization in Medical Oncology at Istanbul University Istanbul Faculty of Medicine in 2013. His journey in medicine began at Istanbul University CerrahpaÅŸa Medical Faculty, where he earned his initial medical degree in 2003, followed by completing his residency in Internal Medicine at the same esteemed institution in 2006.
Professional Affiliations and Leadership
Dr. Yildiz actively contributes to the global medical community through his memberships in renowned professional societies. He is a respected member of the European Society of Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO), affiliations that underscore his commitment to international standards of cancer care. Furthermore, his leadership extends to his role as a Board Member of the Lung Cancer Association, highlighting his influence and dedication to tackling complex oncological challenges. He is also an active member of the Turkish Medical Oncology Association.
Publications and Research Contributions
Dr. Ibrahim Yildiz is an accomplished researcher with a substantial portfolio of published works. His research contributions span critical areas of oncology, including prognostic factors in testicular germ cell tumors, quality of life in colorectal cancer patients, and treatment strategies for esophageal and breast cancers. He has co-authored numerous studies that have appeared in respected journals such as the Journal of BUON and Biomedicine & Pharmacotherapy. His publications, including those focusing on adjuvant chemotherapy in Stage II Colon Cancer, D-dimer correlation with tumor markers, and the impact of Tamoxifen on patient well-being, demonstrate his deep engagement with advancing cancer treatment and patient outcomes.